Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Aortic Valve Pathology in Patients Supported by Continuous-Flow Left Ventricular Assist Device

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Structural and Functional Coronary Artery Abnormalities in Patients With Vasospastic Angina Pectoris

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Edge-to-edge percutaneous repair of severe mitral regurgitation--state-of-the-art for Mitraclip® implantation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Real-world experience of MitraClip for treatment of severe mitral regurgitation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Effect of moderate potassium-elevating treatment in long QT syndrome: the TriQarr Potassium Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Explaining deep neural networks for knowledge discovery in electrocardiogram analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Challenges in catheter ablation of deep myocardial substrate for ventricular tachycardia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Long QT syndrome type 1 and 2 patients respond differently to arrhythmic triggers: The TriQarr in vivo study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Mutations in SCN5A can result in both long QT type 3 (LQT3) and Brugada syndrome (BrS), and a few mutations have been found to have an overlapping phenotype. Long QT syndrome is characterized by prolonged QT interval, and a prerequisite for a BrS diagnosis is ST elevation in the right precordial leads of the electrocardiogram.

METHODS AND RESULTS: In a Danish family suffering from long QT syndrome, a novel missense mutation in SCN5A, changing a leucine residue into a glutamine residue at position 1786 (L1786Q), was found to be present in heterozygous form co-segregating with prolonged QT interval. The proband presented with an aborted cardiac arrest, and his mother died suddenly and unexpectedly at the age of 65. Flecainide treatment revealed coved ST elevation in all mutation carriers. Electrophysiological investigations of the mutant in HEK293 cells indicated a reduced peak current, a negative shift in inactivation properties and a positive shift in activation properties, compatible with BrS. Furthermore, the sustained (I(Na,late)) tetrodotoxin-sensitive sodium current was found to be drastically increased, explaining the association between the mutation and LQT syndrome.

CONCLUSIONS: The L1786Q mutation is associated with a combined LQT3 and concealed BrS phenotype explained by gating characteristics of the mutated ion channel protein. Hence, sodium channel blockade should be considered in clinical evaluation of apparent LQT3 patients.

OriginalsprogEngelsk
TidsskriftCirculation journal : official journal of the Japanese Circulation Society
Vol/bind78
Udgave nummer5
Sider (fra-til)1136-43
Antal sider8
ISSN1346-9843
StatusUdgivet - 6 mar. 2014

ID: 44497841